Company intelligence / Profile preview

NanoSyrinx

Coventry, England, United Kingdomnanosyrinx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company is developing a novel Nanosyringe system for targeted intracellular delivery of biological molecules. No specific clinical results are mentioned as they are still in discovery stage.

Modalities: Protein and peptide therapeuticsbiologic drugs
Industry: Biotech

Partnerships

Eli Lilly and Company (investor and corporate partner)

Beyond the preview

Go deeper on NanoSyrinx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoSyrinx.

Explore the full profile